Iqirvo (elafibranor)

pCPA File Number: 23177
Negotiation Status:
Active Negotiation
Indication(s):
Primary biliary cholangitis
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals Canada, Inc.
CDA-AMC Project Number:
SR0865-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable